486 related articles for article (PubMed ID: 17116835)
1. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
[TBL] [Abstract][Full Text] [Related]
4. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
[TBL] [Abstract][Full Text] [Related]
7. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.
Beissert S; Mimouni D; Kanwar AJ; Solomons N; Kalia V; Anhalt GJ
J Invest Dermatol; 2010 Aug; 130(8):2041-8. PubMed ID: 20410913
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
Mimouni D; Anhalt GJ; Cummins DL; Kouba DJ; Thorne JE; Nousari HC
Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504
[TBL] [Abstract][Full Text] [Related]
10. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
Chams-Davatchi C; Nonahal Azar R; Daneshpazooh M; Valikhani M; Hallaji Z; Barzegari M; Firouz AR; Zakeri M
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.
Ioannides D; Apalla Z; Lazaridou E; Rigopoulos D
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):855-60. PubMed ID: 21752101
[TBL] [Abstract][Full Text] [Related]
12. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
Saha M; Powell AM; Bhogal B; Black MM; Groves RW
Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
[TBL] [Abstract][Full Text] [Related]
13. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
15. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
Katz KH; Marks JG; Helm KF
J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
18. Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Werth VP; Joly P; Mimouni D; Maverakis E; Caux F; Lehane P; Gearhart L; Kapre A; Pordeli P; Chen DM;
N Engl J Med; 2021 Jun; 384(24):2295-2305. PubMed ID: 34097368
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pemphigus vulgaris with mycophenolate mofetil.
Enk AH; Knop J
Lancet; 1997 Aug; 350(9076):494. PubMed ID: 9274594
[No Abstract] [Full Text] [Related]
20. Immunosuppressive therapy for autoimmune bullous diseases.
Meurer M
Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
